Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial.

ESMO open·2026
Same author

PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

QuiCAT: a scalable and flexible framework for mapping synthetic sequences.

Bioinformatics (Oxford, England)·2025
Same author

Response to Letter to the Editor re: "Treatment outcomes of functional urinary incontinence in children after structured urotherapeutic training".

Journal of pediatric urology·2025
Same author

Treatment outcomes of functional urinary incontinence in children after structured urotherapeutic training.

Journal of pediatric urology·2025
Same author

The impact of disease and species differences on the intestinal CLCA4 gene expression.

Journal of molecular medicine (Berlin, Germany)·2025
Same journal

An automated end-to-end pipeline for the management, de-identification, and distribution of whole-slide images using DICOM: An institutional implementation.

Journal of pathology informatics·2026
Same journal

Automatic framework for PD-L1 expression evaluation in Latino patients with non-small cell lung cancer.

Journal of pathology informatics·2026
Same journal

Erratum to "Pathologists in Venice - Real world cases for an immersive training experience": Education, gaming, and show. <i>Journal of Pathology Informatics</i>, Volume 17, 2025, 100418.

Journal of pathology informatics·2026
Same journal

Erratum to PIRO: A web-based search platform for pathology reports, leveraging large language models to generate discrete searchable insights. <i>Journal of Pathology Informatics</i>, Volume 17, 2025, 100436.

Journal of pathology informatics·2026
Same journal

Erratum regarding missing Declaration of Competing Interest statements in previously published articles.

Journal of pathology informatics·2026
Same journal

An integrated AI pipeline for automated cytogenetic analysis of bone marrow karyograms in hematological malignancies: A Pix2Pix enhancement and deep learning detection approach.

Journal of pathology informatics·2026
查看所有相关文章

相关实验视频

Updated: Sep 19, 2025

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.9K

在血管肉瘤中PD-L1表达评估在人工智能支持下得到改善.

F H Reith1,2,3,4, A Jarosch5, J P Albrecht1,2,4

  • 1Max Delbrück Center for Molecular Medicine in the Helmholtz Association.

Journal of pathology informatics
|June 16, 2025
PubMed
概括
此摘要是机器生成的。

人工智能工具可以帮助病理学家准确评估免疫治疗决策的瘤比例得分 (TPS),特别是在罕见的癌症,如血管肉瘤. 这种方法可以提高诊断的准确性,并有助于治疗选择.

关键词:
人工智能辅助的诊断血管肉瘤是一种血管肉瘤.人工智能的人工智能是人工智能.数字病理学数字病理学免疫治疗是一种免疫疗法.在 PD-L1 表达式上.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.7K

相关实验视频

Last Updated: Sep 19, 2025

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.9K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.7K

科学领域:

  • 在瘤学瘤学.
  • 计算病理学计算病理学
  • 人工智能的人工智能

背景情况:

  • 瘤PD-L1表达对于癌症治疗中的免疫疗法选择至关重要.
  • 由于时间限制,病理学家对瘤比例评分 (TPS) 的准确评估具有挑战性,导致观察者之间的一致性较低.
  • 罕见的癌症类型对开发基于AI的预测工具构成数据瓶.

研究的目的:

  • 开发和验证人工智能驱动的管道,用于预测癌症中的瘤比例得分 (TPS).
  • 通过使用预先训练的通用模型,应对罕见癌症的有限培训数据的挑战.
  • 评估人工智能辅助TPS评分在改善病理学评估中的实际实用性.

主要方法:

  • 开发并开源了一个计算管道,利用预先训练的模型进行TPS预测.
  • 应用管道来预测TPS,特别是用于罕见的癌症类型,如血管肉瘤.
  • 促进了反循环,病理学家重新评估了具有显著AI-病理学家分歧的病例.

主要成果:

  • 人工智能管道表现出强大的TPS预测性能,即使训练数据有限.
  • 病理学家经常在审查AI预测后更新他们的TPS得分,这些预测与他们最初的评估有很大不同.
  • 人工智能工具作为一种有价值的"第二意见",提高了诊断准确度.

结论:

  • 基于人工智能的TPS预测工具在技术上是可行的,并且在实际上对协助病理学家非常有价值,特别是在罕见癌症中.
  • 利用通用主义者,预先训练有素的模型克服了开发AI诊断辅助器的数据限制,用于代表性不足的癌症类型.
  • 人工智能协助有可能提高癌症免疫治疗选择的决策质量.